Search

Displaying results 3721 - 3730 of 3917 in total
  1. Drug

    Tertatolol

    go.drugbank.com/drugs/DB13775
    Experimental

    Tertatolol is a beta blocker.

    Categories: Beta Blocking Agents, Non-Selective
  2. Drug

    Bisphenol A

    go.drugbank.com/drugs/DB06973
    Experimental

    Categories: Estrogens, Non-Steroidal
  3. Drug

    Mocetinostat

    go.drugbank.com/drugs/DB11830
    Investigational

    Mocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others.

  4. Drug

    Endralazine

    go.drugbank.com/drugs/DB13435
    Experimental

    Categories: Arteriolar Smooth Muscle, Agents Acting On
  5. Drug

    N4-Hydroxycytidine

    go.drugbank.com/drugs/DB15660
    Experimental

    [A193011] In non-human primates, N4-hydroxycytidine was poorly orally bioavailable.

  6. Drug

    Talniflumate

    go.drugbank.com/drugs/DB09295
    Investigational

    Talniflumate, is an anti-inflammatory molecule studied and used as a mucin regulator in the treatment of cystic fibrosis, chronic obstructive pulmonary disease (COPD) and asthma . In addition, it is used in inflammatory conditions such a...

    Categories: Anti-Inflammatory Agents, Non-Steroidal
  7. Drug

    Cloranolol

    go.drugbank.com/drugs/DB13508
    Experimental

    Categories: Beta Blocking Agents, Non-Selective
  8. Drug

    Castanospermine

    go.drugbank.com/drugs/DB01816
    Experimental

    Categories: Analgesics, Non-Narcotic
  9. Drug

    Trandolaprilat

    go.drugbank.com/drugs/DB14209
    Experimental

    The active metabolite of the prodrug Trandolapril.

    Categories: Agents Acting on the Renin-Angiotensin System
  10. Drug

    Paritaprevir

    go.drugbank.com/drugs/DB09297
    ApprovedInvestigational

    Paritaprevir first came on the market as a fixed-dose combination product with [DB09296], [DB09183], and [DB00503] as the FDA-approved product Viekira Pak. … Depending on the genotype, Paritaprevir is often used in combination with other antivirals such as [DB09296], [DB09183], [DB00503], and [DB00811], with the intent to cure, or achieve a sustained virologic